APPLIED GENETIC TECHNOLOGIES CORP Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2013 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Applied Genetic Technologies Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2013 to Q2 2022.
  • Applied Genetic Technologies Corp Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2022 was $105M, a 24.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $105M +$20.5M +24.5% Jun 30, 2022 10-K 2022-09-27
Q2 2021 $84M +$19.9M +31.2% Jun 30, 2021 10-K 2022-09-27
Q2 2020 $64M +$14.3M +28.6% Jun 30, 2020 10-K 2021-09-23
Q2 2019 $49.8M +$7.56M +17.9% Jun 30, 2019 10-K 2020-09-18
Q2 2018 $42.2M +$1.91M +4.74% Jun 30, 2018 10-K 2019-09-26
Q2 2017 $40.3M +$2.89M +7.73% Jun 30, 2017 10-K 2018-09-11
Q2 2016 $37.4M +$567K +1.54% Jun 30, 2016 10-K 2017-09-13
Q2 2015 $36.8M +$12.8M +53% Jun 30, 2015 10-K/A 2017-09-08
Q2 2014 $24.1M +$5.13M +27.1% Jun 30, 2014 10-K 2015-09-10
Q2 2013 $19M Jun 30, 2013 10-K 2014-09-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.